10th May 2012 11:02
Not for release, publication or distribution directly or indirectly, in whole or in part, in or into or from the United States of America (including its territories and possessions, any state of the United States, and the District of Columbia), Canada, Australia, the Republic of South Africa, the Republic of Ireland or Japan, or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.
This press release does not constitute or form a part of, and should not be construed as, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities in MyCelx Technologies Corporation ("MyCelx" or the "Company").
THE COMPANY'S COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR ANY STATE SECURITIES LAWS (THE "STATE ACTS") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS THE SECURITIES ARE REGISTERED UNDER THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS IS AVAILABLE.
MyCelx Technologies Corporation
("MyCelx" or the "Company") (AIM: MYX)
10 May 2012
Result of Annual Meeting
The Company is pleased to announce that, at its Annual Meeting held on 9 May 2012 at the offices of Addleshaw Goddard LLP, Milton Gate, 60 Chiswell Street, London EC1Y 4AG, United Kingdom, the resolutions set out in the Notice of Annual Meeting were duly passed,
Grant of Share Option to Director
The Company announces that a director was granted an option on 9 May 2012 under the MyCelx Omnibus Performance Incentive Plan over the Company's common shares of US$0.025 each. This grant formed part of wider grants of 53,400 options to a total of three employees across the Company, on the same date. The grant to the director was as follows:
Name of Director | Number of share options granted | Exercise price | Total number of share options held following this notification | Total number of share options as % of current issued share capital |
Swinton Griffith | 26,000 | US$3.87 * | 26,000 | 0.2% |
*Based on the mid-market closing price of the Company's common shares at 9 May 2012, and the closing US/£ exchange rate at that date.
The share option granted on 9 May 2012 will vest on 1 January 2016 and is exercisable between 1 January 2016 and 31 December 2016, subject to the restrictions on dealing under the Company's share dealing code. Swinton Griffith does not hold any other shares in the Company.
For further information please contact:
MyCelx Technologies Corporation
Connie Mixon, CEO
David Pattillo, CFO
Tel: +1 888 306 6843
Numis Securities Limited
Corporate Finance
Alastair Stratton
Stuart Skinner
Jamie Loughborough
Corporate Broking
James Black
Ben Stoop
Tel: +44 20 7260 1000
Pelham Bell Pottinger
Mark Antelme
Nick Lambert
Henry Lerwill
Tel: +44 20 7861 3232
Related Shares:
Mycelx Di S